PMID: 12139558Jul 26, 2002Paper

Inflammatory changes in the lungs of premature infants with symptomaticpatent ductus arteriosus

Pediatrics International : Official Journal of the Japan Pediatric Society
Toshihiko NakamuraYunosuke Ogawa


The aim of the study was to observe the inflammatory changes during the therapy for symptomatic patent ductus arteriosus (sPDA). We investigated biochemically the sample of the tracheobroncheal aspirates (TA) from 11 intubated premature infants. Three i.v. doses of indomethacin (0.2 mg/kg)were administered with 24-h intervals. The samples were divided into two groups, the effective occasions (n = 10)and non-effective occasions (n = 6). The amounts of myeloperoxidase (MPO), soluble L-selectin (sL-selectin)in TA, and the polymorphonuclear leukocytes (PMN) of peripheral blood stream and TA were analyzed before and after treatment ofsPDA with indomethacin. In effective occasions, there were significant decreases of peripheral PMN and MPO and PMN in TA. However, this group had a significant increase of sL-selectin. In non-effective occasions, five out of six samples had decreases of MPO and PMNin TA, but not significantly. In contrast, there was a significant decrease of sL-selectin. These data suggested that anti-inflammatory change after closure of sPDA may be caused by not only indomethacin itself, but also ductal closure itself. However, further study is necessary to clarify the relationship between the closure of the ductus its...Continue Reading


Dec 1, 1992·Acta Paediatrica Japonica; Overseas Edition·Y OgawaH Togari
Oct 1, 1973·Journal of Pediatric Surgery·J H GayM E Molthan
Jul 1, 1993·Archives of Disease in Childhood·S ArnonM Silverman
Apr 16, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·N KoyamaK Kaneko
May 13, 1998·Archives of Disease in Childhood. Fetal and Neonatal Edition·S KotechaN Klein
Mar 27, 1999·Pediatric Pulmonology. Supplement·Y OgawaT Nakamura


Oct 8, 2005·Biology of the Neonate·E BancalariAlvaro Gonzalez

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.